Åú¨§¯gÄ_Ä_¥i¥H¨Ï¥Î§t¦³»TorÂȦç¯óºëªo¤§¨¾°A¶K¤ù¶Ü?
ami
2005/07/05 ¤W¤È 11:49:58 Åú¨§¯gÄ_Ä_¥i¥H¨Ï¥Î§t¦³»TorÂȦç¯óºëªo¤§¨¾°A¶K¤ù¶Ü?
Re: Åú¨§¯gÄ_Ä_¥i¥H¨Ï¥Î§t¦³»TorÂȦç¯óºëªo¤§¨¾°A¶K¤ù¶Ü?
¥x¤¤ºaÁ`--³\¹ÅµXÂå®v
[email protected]
2005/07/05 ¤U¤È 04:15:41
Dear Ami, ¸g¬d¾\°ê¤º¥~¤åÄm¡A¨ÃµL¬ÛÃö³ø§i»¡»T©ÎÂȦç¯óºëªo·|¤Þ°_Åú¨§¯g±wªÌ·»¦å¤ÏÀ³¡C¤ñ¸û±`µo¥Íªº²{¶H¬O¹L±Ó¤ÏÀ³¡CÅú¨§¯gÄ_Ä_¥un²×¥Í¦b¤é±`¥Í¬¡¤Wª`·N¥H¤U´X¥ó¨Æ,§Y¥iÁקK²£¥ÍÄY«·»¦å¤ÏÀ³,¥¦wªø¤j¡C¥]¬A:¤£ÀH·NªAÃÄ,©Ò¦³ÃĪ«§¡»Ý¸g¥ÑÂå®v³B¤è¡C¥Í¯f®ÉÀ³¥D°Ê§iª¾ÂåÅ@¤Hû¤p«Ä±w¦³¦¹¯g¡C¤£¦YÅú¨§¤Î¨ä»s«~¡C¨ü¶Ë®É¤£n¨Ï¥ÎµµÃĤô¡C¦çÃo¤Î´Z©Ò¤£©ñ¼Ì¸£¤Y¡C°²Yµo²{¦³¶À¯n©Î³h¦å©Î§¿¦â¸û²`¦p¯ù¯ëµ¥²{¶H,À³¾¨³t´NÂå¡CÁÂÁ§Aªº¨Ó«H--¥x¤¤ºaÁ`--³\¹ÅµXÂå®v
¥D¦®¡GÅú¨§¯g
³ö¼ü
2005/06/08 ¤U¤È 08:43:26
½Ð°ÝÅú¨§¯g¸ò¥±`¤Hªº¹Ø©R¤@¼Ë¶Ü? ·|¤£·|¤ñ¥±`¤HÁÙnµu?
Re: Åú¨§¯g
¥x¤¤ºaÁ`--³\¹ÅµXÂå®v
2005/06/08 ¤U¤È 11:30:57
³ö¼ü, Åú¨§¯g±w¨à¥un²×¥Í¦b¤é±`¥Í¬¡¤Wª`·N¥H¤U´X¥ó¨Æ,§Y¥iÁקK²£¥ÍÄY«·»¦å¤ÏÀ³,¥¦wªø¤j¡C¥]¬A: 1.¤£ÀH·NªAÃÄ,©Ò¦³ÃĪ«§¡»Ý¸g¥ÑÂå®v³B¤è¡C2.¥Í¯f®ÉÀ³¥D°Ê§iª¾ÂåÅ@¤Hû¤p«Ä±w¦³¦¹¯g¡C3.¤£¦YÅú¨§¤Î¨ä»s«~¡C4.¨ü¶Ë®É¤£n¨Ï¥ÎµµÃĤô¡C5.¦çÃo¤Î´Z©Ò¤£©ñ¼Ì¸£¤Y¡C6.°²Yµo²{¦³¶À¯n©Î³h¦å©Î§¿¦â¸û²`¦p¯ù¯ëµ¥²{¶H,À³¾¨³t´NÂå¡C¥un¤@ª½ª`·N³o´X¥ó¨Æ, ¹Ø©R»P±`¤HµL²§¡CÁÂÁ§Aªº¨Ó«H!--¥x¤¤ºaÁ`--³\¹ÅµXÂå®v
Åú¨§¯gÄ_Ä_¥i¥H¦Y§t¦³"¤s±ù¾J"ªº¿}ªG©Î¹«~¶Ü?
Chiner
2005/06/21 ¤U¤È 01:47:25
½Ð°ÝÅú¨§¯gÄ_Ä_¥i¥H¦Y§t¦³"¤s±ù¾J"ªº¿}ªG©Î¹«~¶Ü? ¹ª«¤¤°£¤F§t¦³"Åú¨§"¦¨¥÷¤§¥~, ÁÙ¦³n¥t¥~ª`·Nªº¶Ü? ÁÂÁÂ!
Re: Åú¨§¯gÄ_Ä_¥i¥H¦Y§t¦³"¤s±ù¾J"ªº¿}ªG©Î¹«~¶Ü?
¥x¤¤ºaÁ`--³\¹ÅµXÂå®v
2005/06/21 ¤U¤È 03:34:40
Dear Chiner, ¤s±ù¾J¡]Sorbitol¡^¬O±q¸²µå¿}µõ¸Ñ²B¤Æ¦Ó±o¡C¸g¬d¾\°ê¤º¥~¤åÄm¡A¨ÃµL¬ÛÃö³ø§i»¡·|¤Þ°_Åú¨§¯g±wªÌ·»¦å¤ÏÀ³¡C¥un²×¥Í¦b¤é±`¥Í¬¡¤Wª`·N¥H¤U´X¥ó¨Æ,§Y¥iÁקK²£¥ÍÄY«·»¦å¤ÏÀ³,¥¦wªø¤j¡C¥]¬A:¤£ÀH·NªAÃÄ,©Ò¦³ÃĪ«§¡»Ý¸g¥ÑÂå®v³B¤è¡C¥Í¯f®ÉÀ³¥D°Ê§iª¾ÂåÅ@¤Hû¤p«Ä±w¦³¦¹¯g¡C¤£¦YÅú¨§¤Î¨ä»s«~¡C¨ü¶Ë®É¤£n¨Ï¥ÎµµÃĤô¡C¦çÃo¤Î´Z©Ò¤£©ñ¼Ì¸£¤Y¡C°²Yµo²{¦³¶À¯n©Î³h¦å©Î§¿¦â¸û²`¦p¯ù¯ëµ¥²{¶H,À³¾¨³t´NÂå¡CÁÂÁ§Aªº¨Ó«H--¥x¤¤ºaÁ`--³\¹ÅµXÂå®v
Åú¨§¯g^¤åª©³Æ§Ñ¥d
¯³¸Ö©ù
2005/04/16 ¤U¤È 02:13:00
¥i¥H±Hµ¹§ÚÅú¨§¯g^¤åª©³Æ§Ñ¥d¶Ü? ©Î¬O§i¶D§Úþ¸Ì¥i¥H¨ú±oªü! §Ú¥X°êŪ®Ñ®Én¨Ï¥ÎªºÁÂÁ§A
Re: Åú¨§¯g^¤åª©³Æ§Ñ¥d
¥x¤¤ºaÁ`--³\¹ÅµXÂå®v
[email protected]
2005/05/09 ¤W¤È 11:46:36
Dear ¸Ö©ù, Compounds commonly reported in the literature that may induce hemolysis in G6PD deficient individuals (compiled from: Avery, 1980; Koda-Kimble, 1978).ÁÂÁ±zªº¨Ó«H¡I¥x¤¤ºaÁ`--³\¹ÅµXÂå®v
§Ú¦³Åú¨§¯g
¤p¶Â
2005/04/07 ¤U¤È 04:53:32
¦A®a¸Ì«ÜµL²áªº§Ú ¦Y»æ°® ¤@¤p¥]¤@¤p¥] ¦³µÃ¨§ Åú¨§ªº §Ú¤£¤p¤ß¦Y¨ì¤@¥]Åú¨§ªº §Ú¥u¦Y¤F¤@Áû¥Ø«e§Úªº¨Åé¨S¦³²§ª¬ §Ú¬OÓ17·³ªº¤k¥Í½Ð°Ý§Ú·|¤£·|«ç»ò¼Ë??§Ú¥u¦Y¤F¤@Áû..³Â·Ð§Ö³tÀ°§Ú¸Ñµª..§Ú«Ü¾á¤ß>"<
Re: §Ú¦³Åú¨§¯g
¥x¤¤ºaÁ`--³\¹ÅµXÂå®v
2005/05/09 ¤U¤È 12:05:02
Dear ¤p¶Â, ¦pªG¤wÀËÅç¹L½T©w¬OÅú¨§¯g±wªÌ¡A¶·ÁקKÃþ¦ü±¡ªp¡A¦p¦³Áy¦â»a¥Õ¡B¥þ¨¶À¯n¤Î¸Ñ²`¯ù¦â§¿¡An¾¨³t°eÂå¨D¶E¡CÁÂÁ±zªº¨Ó«H¡I¥x¤¤ºaÁ`--³\¹ÅµXÂå®v
G6PD
Chen
2005/06/21 ¤U¤È 06:56:04
½Ð°Ý G6PD Åú¨§¯gªº¤H¥i¥H¦Y´¶®³¯k©Î¥Îvoltaren¶Ü? thanks
Re: G6PD
¥x¤¤ºaÁ`--³\¹ÅµXÂå®v
2005/06/22 ¤U¤È 02:16:32
Dear Chen, Åú¨§¯g±wªÌÀ³ÁקK¨Ï¥ÎªºÃĪ«¤Î¤Æ¾Çª««~¦p¤U: 1.§ÜºÄ¯eÃĪ«,¦p: Primaquine, Pamaquine, Pentaquine, Plasmoquine¡C 2.§Ü·P¬VÃĪ«¤¤ªºÁDÓiÃÄ,¦p: Sulfanilamide, Sulfapyridine, Sulfioxazole,Salicylazosulfapyridine, Sulfamethoxypyridazine, Sulfacetamide¡C 3.¬Y¨Ç¸Ñ¼ö¤îµhÃÄ,¦p: Aspirin, Acetanilide, Phenacetin, Antipyrine, Aminopyrine, P-Aminosalicylic acid¡C 4.¬Y¨Ç§Ü·P¬V©Î®ø¬r¾¯,¦p: Nitrofurantoin, Furazolidone,Furaltadone¡C 5.¯S§Oªº¤Æ¾Ç«~¤ÎÃĪ«,¦p: Naphthalene, ÀsÁxµµ,¥Ò°òÂÅ,Phenlhydrazine, Acetylphenyl hydrazine, Probenecid(«P§¿»Ä±Æªn¾¯), Sulfoxone¡C Acetaminophen(Panadol)©MDiclofenac(Voltaren)¨Ã¤£¦b¤Wz©Ò¦CÃĪ«¤§¤¤,¤@¯ë¨Ó»¡¬O¥i¥H¨Ï¥Îªº¡CÁÂÁ§Aªº¨Ó«H!!-¥x¤¤ºaÁ`--³\¹ÅµXÂå®v
½Ð°ÝÅú¨§¯g¥i§_¨Ï¥ÎÁ¡²ü¤ÎÁ¡²ü¸£¦¨¥÷ªº¥Î«~©O? Y¤pªB¤Í¦³¥~¶Ë¥i§_¨Ï¥Î½¯¨q¹p´°©O?Y¤£¦æ¥i§_«Øij¨Ï¥ÎªºÃÄ»I©O?
§õ©gÄÁÂå®v¦^ÂСG
®Ú¾Ú½Ã¥Í¸pªº³ø§i¡A°Ò¨q¹p´°³n»I¤¤§t¦³Methyl Salicylate¡]¥Vºñªo¡A¥Ò°ò¤ô·¨»Ä¡^¡B Camphor¡]¼Ì¸£ªo¡^¡BMenthol¡]Á¡²ü¸£¡^; ¦ÓºñªoºëÅ¥»¡¬O§t¦³¼Ì¸£ªo, ¤×¥[§Qºëªo, ¤B»ªo, Á¡²üªo»P¥Ò°ò¤ô·¨»Ä. ¸g¬d¤åÄm, ¥Ø«eÁÙ¨S¦³§ä¨ìMethyl Salicylate, Camphor, Menthol´¿¤Þ°_Åú¨§¯g·»¦åªº³ø§i. ¦ý¥Ñ©ó³o¨ÇªF¦è¹ï¥Ö½§¦³¨ë¿E©Ê, «Øij¤T·³¥H¤U¤p«ÄºÉ¶q¤£n¨Ï¥Î¡C
½Ð°Ý¦³¬ã¨s³ø§i»¡þ¨ÇºëªoÅú¨§¯g¤£¯à¨Ï¥Î¶Ü? ¦]²{¦b«Ü¦h°Ó«~³£¦³²K¥[£¸¨Çºëªo¦¨¤À
³¢´f¬Ã±M¥ô§U²z¦^ÂСG
Åú¨§¯gÁקK±µÄ²ªºª««~¤ÎÃĪ«¡A½Ð¨£G6PD¯e¯f²¤¶¡A«Øij±z¦b¨Ï¥Î¥ô¦ó°Ó«~«e½Ð¥J²Ó¸Ô¾\²£«~ªº¦¨¤À»¡©ú¡A½T»{µL»~«á¦A¨Ï¥Î¡A¦]¬°¥«±¤W²£«~²³¦h¡A±z´£¨Ñªº°T®§¦³¡A©Ò¥H¶È¦b¦¹§@¤@µu½g»¡©ú»P´£¿ô¡C
¯à§_¸É¥RÅK¾¯?(2004/08/09)
G6PD³h¦å±wªÌ¤Î¦a¤¤®ü«¬³h¦å¯à§_¸É¥RÅK¾¯?
¶À²»³ÕÂå®v¦^ÂСG
G6PD³h¦å±wªÌ¤Î¦a¤¤®ü«¬³h¦å¬Ò«D¦]¯ÊÅK¤Þ°_,¸É¥RÅK¾¯¨Ã¤£«ê·í.
¤ÑµMªá¯ó¯ù¡AÄ_Ä_¥i¥H¶¼¥Î¶Ü¡H(2004/08/03)
±z¦n~ §Úªº¨à¤l10Ó¤ë¤F¡A§Ú·Qµ¹¥L³Ü¢ð¢ñ¢ø¢øªº¤ÑµMÄ_Ä_ªá¯ó¶¼¡A¸Ì¦¨¥÷¦³¥Ìµâ¡D¤j¯õ»¡D¯õ»µ¥¼Ú¬wªá¯ó¡A§Ú¥´¹q¸Ü¥h¸Ó¤½¥q°Ý¡A¦o»¡n°ÝÂå¥Í¡A¤£ª¾¹D¥i¤£¥i¥H¡H¡H¬O§_¡A¤ÑµMªº¹ª«¡A³£¥i¥H¦Y¡A¨Ò¦p¡G«n¥Ê¡D¡DÁÂÁ¡ã
¶À²»³ÕÂå®v¦^ÂСG
¨ÃµL¬d¨ìÅú¨§¯g¨à¤£¯àªA¥Î¥Ìµâ¡D¤j¯õ»¡D¯õ»µ¥¼Ú¬wªá¯ó¡A¦Ü©ó«n¥Ê«hÀ³µL°ÝÃD¡A10Ӥ몺¤p«Ä¨ÃµL¶¼¥Î¦¨¥÷¦p¦¹½ÆÂøªºªá¯ó¶¼¤§¶·n¡A½Ð±z¤T«ä¦Ó«á¦æ¡C
Ä_Ä_¨{¤lº¦®ð¡A¤£ª¾¥i¥HÀ¿¨º¤@ºØÃÄ»I¤~¦n¡H(2004/08/01)
§Úªº¤p«Ä¦³Åú¨§¯g¦]¬°¨{¤lº¦®ð¤£ª¾¥i¥HÀ¿¨º¤@ºØÃÄ»I¤~¦n??½Ð§i¶D§ÚÃÄ«~¦WºÙÁÂÁÂ~
¶À²»³ÕÂå®v¦^ÂСG
Åú¨§¯g¯f¤HÀ³¸ÓÁקK¨Ï¥Î¤U¦CÃÄ«~¡G
¤@¡B§ÜºÄ¯eÃĪ«¡A¨Ò¦p primaquine¡Apamaquine¡Apentaquine¡Aplasmoquine¡C
¤G¡B§Ü·P¬VÃĪ«¤¤ªºÁDÓiÃÄ¡A¨Ò¦p sulfanilamide¡Asulfapyridine¡Asulfisoxazole¡Asulfacetamide¡Bsalicylazosulfapyridine¡Asulfamethoxypyridazine¡C
¤T¡B¸Ñ¼ö¤îµh¾¯¡A¨Ò¦p aspirin¡Aacetanilide¡Aphenacetin¡Aantipyrine¡Aaminopyrine¡Ap-aminosalicylic acid¡C
¥|¡B¬Y¨Ç§Ü·P¬V©Î®ø¬r¾¯¡A¨Ò¦p nitrofurantoin¡Afurazolidone¡Afuraltadone¡C ¡@¡@¤¡B¨ä¥L¤Æ¾Ç«~¡A¨Ò¦p²þ¡]naphthalene¡^¡AÀsÁxµµ¡A¥Ò°òÂÅ¡]methylene blue¡^¡Aphenylhydrazine¡Aacetylphenylhydrazine¡Aprobenecid¡]°§¿»Ä¾¯¡^¡Asulfoxonoe¡C
¦pªGÃÄ»I¤£§t¥H¤W¦¨¥÷¥H¤Î¼Ì¸£ªoÀ³¬O¤ñ¸û¦w¥þªº
¥i¥H¦Y¯»¥ú©Î¥VÂήL¯óµ¥¶}GÃĶܡH(2004/07/27)
§Ú¨à¤l¬OÅú¨§¨à¡A¥Ø«e¬O¤EÓ¦h¤ë¡AÁÙ¤£¬O«Ü·|§¤¡A¤]¤£·|ª¦¡A·Q½Ð°Ý~Åú¨§¨à¥i¥H¦Y¯»¥ú©Î¥VÂήL¯óµ¥¶}G¤¤ÃĶÜ~ÁÂÁÂ~
¶À²»³ÕÂå®v¦^ÂСG
±zªº¤pªB¤Í¦³¥i¯à¦³¹B°Êµo¨|ªº¿ð½w¡AÀ³¦Ü¤jÂå°|½Ð¤p¨à¯«¸g¬ìÂå®vµû¦ô¡A¥Ø«e¤âÃä¨ÃµL¸ê®ÆÅã¥ÜÅú¨§¨à¥i¥H©Î¤£¥i¥H¦Y¯»¥ú©Î¥VÂήL¯óµ¥¶}G¤¤ÃÄ¡A¦ý¤¤ÃĦ¨¤À½ÆÂø¡A¥B¦³¥i¯à§t¦³¬r¤§«ª÷ÄÝ¡A¨Ã¤£¤Ó¾A¦XÀ¦¨à¹¥Î¡A½Ð¤T«ä¦Ó«á¦æ¡C
³Q°A¤l¥m«r¡A¥i¥H¨Ï¥Î¤pÅ@¤h¶Ü¡H(2004/07/26)
¤@¯ëÅú¨§¯g£x¹w¨¾§Ú³£ª¾¹D¡A·Q½Ð°Ý¤@¤U¡A§Ú£xÄ_Ä_¥Ø«e2·³¤F¡A¦³®ÉÔ§Ú¸ò§Ú¥ý¥Í·|±a¥L¥h¤á¥~¨«¨«¡A½Ð°Ý¼Ì¾ð¹ï§Ú£xÄ_Ä_·|¦³¼vÅT¶Ü¡H¦³®É³Q°A¤l¥m·Q¥Î<¤pÅ@¤h>¶î©Ù¡A¦ý¬O¤@¬Ý¨ì¦¨¥÷§t¦³camphor´N¤£´±Åý¥L¨Ï¥Î¡A¤@¯ë£xÃÄ»I¦³£x³£·|§t¦³³oºØ¦¨¥÷¡A¬O§_¤£¯à¨Ï¥Î©O¡H®L¤Ñ¨ì¤F¡A§Ú·Q¶R§t¦³»TªºªÎ¨mÅý§Ú£xÄ_Ä_¥Î¡A¤£ª¾¹D¯à§_¨Ï¥Î¡H
¶À²W¼wÂå®v¦^ÂСG
¤@¯ë¼Ì¾ð¤£·|³y¦¨¤pªB¤Íªº¼vÅT¡A§t¦³camphor¦¨¤ÀªºªF¦èºÉ¶qnÁקK¡A§t»TªºªÎ¨m¡A¥i¯àÁÙ¬Onª`·N¨ä©Ò§tªº¦¨¤À¡C
Y¤p«Ä«K¯¦¡A¥i¥H¥[¤JY¤¸¿õ¶Ü¡H(2004/07/05)
§Úªº¤p«Ä¤l§Ö9Ó¤ë¤F,¥u¦³7¤½¤ç,¨CÀ\³Ü¤£¨ì150cc..¤S®e©ö«K¯¦..¡A²{¦b³£¤£Ä@·N¥X¤O«K«K¤F~§Ú·Q¥[¤J"Y¤¸¿õ¡¨¡A¤£ª¾¹DÅú¨§¯g¡A¥i¥H¦Y¶Ü¡H¡H¡H¤@¯ëªº¹ª«¡DÀ³¸Ó³£¥i¥H§a¡ã¥un¨S¦³¼Ì¸£¤Y§a¡ã¨N¯D¨Å¡A¦³¦ã¯óªº¡A¬O§_¤]¥i¥H©O¡H¡H¡þÁÂÁÂ
¶À²W¼wÂå®v¦^ÂСG
¦b¤é±`¥Í¬¡ùØ¡AÅú¨§¯g¯f¤Hnª`·Nªº¡A¥]¬AÁקK¦YÅú¨§¡A¦çÂd¤Î´Z©Òùؤ£¥i¥H¨Ï¥Î¼Ì¸£¤Y¡A¨ü¶Ë®É¤£n¨Ï¥Î§tÀsÁxµµªº®ø¬r¤ô¡A¨Ò¦pµµÃĤô¡A¥H¤Î¦³¯f®É¤£¥i¥H¦Û¦æªA¥Î¦¨ÃÄ¡AÀ³¸Ó½Ð±ÐÂå®v©ÎÃÄ®vµ¥µ¥¡C¤@¯ëªº¹ª«À³¸Ó¥i¥H¹¥Î¡A±zªº¤p«ÄÅ髪º½T¸û»´¡A«Øij±z±aµ¹¤p¨à¸zG¬ìÂå®vµû¦ô´M¨DÀ°§U¡AY¤¸¿õÀ³¸Ó¬O¥i¥H¨Ï¥Î¡A¦ý¬O³Ì¦nÁÙ¬O¸g¹LÂå®vµû¦ô¥Íªø¿ð½wªºª¬ªp¡A¦Ó¤£n¾Õ¦Û¥ÎÃÄ¡C
¼Ì¾ð®a¨ã¬O§_¦³¼vÅT¡H(2004/06/18)
¥Ñ©ó®a±Ú¤º¦³Åú¨§¯gªº¤p«Ä¡A¦]¦¹·Q½Ð±Ð¤@¨Ç°ÝÃD 1.¥H«á¤p«Ä¬O§_«Ü¦³¥i¯à¤]·|¦³Åú¨§¯g¡H 2.Y¬OÁʶR¼Ì¾ð©Ò»s³yªº³ÃÑ(¨Ò¦pÀ\®à¡B§É²Õµ¥¼Ì¾ð³ÃÑ¡A¦³ªº·|¦³¼Ì¾ðªº¨ý¹D)¡A¬O§_¹ï¦³Åú¨§¯gªº¤p«Ä¦³¼vÅT¡H¼Ì¾ðªº¨ý¹D¬O¤£¬O¹³¼Ì¸£¤Y¤@¼Ë·|¹ïÅú¨§¯gªº¤H³y¦¨¼vÅT¡H¥H¤W°ÝÃD·Ð½Ð¸Ñµª¡CÁÂÁ¡I
¦¶³ÍÅïÂå®v¦^ÂСG
®a±Ú¤º¦³Åú¨§¯gªº¤p«Ä¡A¥H«á¥Í¤U¤p«Ä¦³Åú¨§¯gªº¾÷²v¥i¯à¤ñ¥¿±`¤H°ª¤@¨Ç¡A¤£¹L¥Ø«eÅú¨§¯g¤w¸g¦C¤J·s¥Í¨à¿zÀ˪º±`³WÀˬd¡A¼Ì¾ð©Ò»s³yªº³ÃѨ䣷|¹ïÅú¨§¯gªº¤H³y¦¨¼vÅT¡C
Åú¨§¯g©ÒÀË´úªº¼ÆȦ³¤À°ª©Î§C¶Ü¡H(2004/06/01)
½Ð°ÝÅú¨§¯g©ÒÀË´ú¥X¨ÓªºÈ¡A¦³¤À¬°°ª©Î§C¶Ü?Åú¨§¯gªº±wªÌ¡A¨ä¦å²G¤¤"¤@©w¨S"G6PD¶Ü?ÁÙ¬O¦å²G¤¤"¦³"G6PD¡A¥u¬OG6PD¤ñ¸û¤Ö©O?°·«O¦³µ¹¥I¶Ü? ÁÂÁ¦^ÂÐ
¦¶³ÍÅïÂå®v¦^ÂСG
¥x¤jÂå°|ªºG6PD¼ÆÈ<5U/gHb¥i¥H½T©w¶EÂ_G6PD¯Ê¥F¯g(Åú¨§¯g)¡A¨CÓÂå°|¦]ÀËÅç¾÷¾¹¤£¦P¡A¼ÆÈ¥i¯à¦³¤@¨Ç®t²§¡A¦ý¬O¦pªG"³æ¦ì"¬Û¦P(U/gHb)¡A¼ÆÈÀ³¸Ó«Ü±µªñ¡A³oÓ¯e¯f¾É¦]©óG6PDªº¯Ê¥F¡A¦å²G¤¤¦³G6PD¡A¥u¬OG6PD¤£¨¬¡A¥~¨Óªº®ñ¤Æ¨ë¿E·|³y¦¨¬õ¦å²y·»¦å¡A°·«O¦³µ¹¥I³oÓ¯e¯fªºÀˬd¡AÁÂÁ±zªº¨Ó«H¡C
¨ì©³þ¨Ç¹ª«§t¦³Åú¨§¤£¯à¦Y¡H(2004/05/24)
§Úªº¤pÄ_Ä_¦³Åú¨§¯g¡A¨ì©³þ¨Ç¹ª«§t¦³Åú¨§¤£¯à¦Y¡H
¶À²»³ÕÂå®v¦^ÂСG
§t¦³Åú¨§ªº¹ª«¥i°Ñ·Ó¹«~¥]¸Ëªº¼Ð»x¡A¥¿±`±¡ªp¤U³£·|¦³¼Ð»x©ÎªÌ²£«~¤W¦³"Åú¨§"µ¥¦r²´¡A½Ð©ó¹¥Î¹ª««e¸Ô¾\¹ª«¥]¸Ë»P»¡©úªí¤W»¡©ú¡C
Åú¨§¯g¤p«Ä¥ÎÃÄ°ÝÃD¡H(2004/05/21)
±z¦n¡A§Ú¨à¤l²{¦b¤@·³¡A¥L±`³Q°A¤l«r¡A§Ú¤p©h¬OÓÅ@¤h¡A¦o®³¤F¤@²~Ãĵ¹¥L¶î©Ù¡A¥Ø«e³£µL²§ª¬¡A¦ý§Ú¤µ¤Ñ¤Wºô¬d¨ì¨ä¤¤¤@Ó¦¨¥÷¬OCamphor(¼Ì¸£ªo)¡A§Ú¦n¾á¤ß¡A³oºØÃÄ¥i¥Hµ¹Åú¨§¯gªº¤p«Ä¶î©Ù©Î¦Y(¥L¦³®É·|¶ÃºN¡AµM«á¤â¤S©ñ¦b¼L¤Ú)¶Ü¡H
¶À²»³ÕÂå®v¦^ÂСG
¤@¯ë¦Ó¨¥¬O»¡Åú¨§¯g±wªÌ¤£¥i±µÄ²©`¤Y(¯ä¤Y)¡A¯ä¤Y¬O¥Ñ©`(Naphthalene¤À¤l¦¡ C10H8)»s³y¦Ó¦¨¡A©`¤Y¬O±qìªo©Î·ÑµJªo´£¨úªº¤@ºØ¸YÀôªÚÖL¤Æ¦Xª«¡C¥¦ª@µØ¥X¨Óªº"¯ä"®ð¦³¬r©Ê¡A¤×¨ä¶Ë®`¨xŦ¡A¼Ì¸£¬Oà¬Ãþ¡A¤À¤l¦¡¬°C10H16O¡C¥¦¬O±q¤ÑµM¼Ì¤ì±o¨ìªº´¹Ê^¡C¥¦¯S§Oªº»¨ý¥Ñ´¹Ê^ª@µØ¥X¨Ó¡A¯à°÷¥Î©óÂåÃĤιw¨¾©øÂγE»kµ¥¤è±¡C¥¿¦]¬°¥¦ªº»¨ýµL¬r©M¹ï¤HÅé©M¦çªA¸ûµLÃa¼vÅT¡A¦ý¬O¥Ñ©ó¤£½T©w¥«°âªº¼Ì¸£ªo¬O§_§t¦³Naphthaleneµ¥®ñ¤Æ¾¯Âø½è¡A¦]¦¹«Øij±z¤´¥HºÉ¶qÁ׶}¬°ì«h¡AY±zªº¤p«Ä¦³¶À¯n¡A³h¦å¡Aµê®zµ¥¯gª¬À³³t°eÂå¡C¥t¥~¼Ì¸£ªo¤£¥i¹¤J¡A¦]¬°¹ï¤HÅ餴¬°¦³®`¡C
Åú¨§¯g¥i¥HÀ¿"³ßÀø§´"¡H(2004/04/16)
¥i¥HÀ¿"³ßÀø§´¶Ü??¦]¬°¤â«ü³Q§¨¨ì¤F~¤£ª¾¥i¥HÀ¿¤°»òÃĤ~¦n??Åú¨§¯g¥i¥HÀ¿¥ô¦ó²£«~ªºÃÄ»I¶Ü??ÁÂÁÂ~
¶À²W¼wÂå®v¦^ÂСG
±z¦n:¤é±`¥Í¬¡ùØ¡AÅú¨§¯g¯f¤Hnª`·N´X¥ó¨Æ¡A¥]¬AÁקK¦YÅú¨§¡A¦çÂd¤Î´Z©Òùؤ£¥i¥H¨Ï¥Î¼Ì¸£¤Y¡A¨ü¶Ë®É¤£n¨Ï¥Î§tÀsÁxµµªº®ø¬r¤ô¡A¨Ò¦pµµÃĤôµ¥.¨Ã¥BÁקK¨Ï¥Î¤U¦CÃÄ«~¡G¤@¡B§ÜºÄ¯eÃĪ«¡A¨Ò¦p primaquine¡Apamaquine¡Apentaquine¡Aplasmoquine¡C
¤G¡B§Ü·P¬VÃĪ«¤¤ªºÁDÓiÃÄ¡A¨Ò¦p sulfanilamide¡Asulfapyridineµ¥¡C
¤T¡B¸Ñ¼ö¤îµh¾¯¡A¨Ò¦p aspirin¡Aacetanilide¡Aphenacetin¡Aantipyrine¡Aaminopyrine¡Ap-aminosalicylic acid¡C
¥|¡B¬Y¨Ç§Ü·P¬V©Î®ø¬r¾¯¡A¨Ò¦p nitrofurantoin¡Afurazolidone¡Afuraltadone¡C
¤¡B¨ä¥L¤Æ¾Ç«~¡A¨Ò¦p²þ¡]naphthalene¡^¡AÀsÁxµµ¡A¥Ò°òÂÅ¡]methylene blue¡^¡Aphenylhydrazine¡Aacetylphenylhydrazine¡Aprobenecid¡]°§¿»Ä¾¯¡^¡Asulfoxonoeµ¥µ¥. ³ßÀø§´À³¸Ó¬O¥i¥H¨Ï¥Îªº
Åú¨§¯gªºÀËÅç¼ÆÈ¡H(2004/04/08)
±z¦n!!§Ú®ababy¤TÓ¤ë¤j¡AÀˬd¥X¦³Åú¨§¯g(¤÷¥À¬ÒµL¯gª¬)¡AÀË¥XªºÈ¬O0.3¡A¥»¤H¦³¤Wºô¬d¸ß¬ÛÃöªº¸ê°T¡A¦ý¬OÃö©óÀË¥XȪº³¡¤À¡A¦n¹³¤ñ¸û¨S¦³´£¨ì.·Qn½Ð°Ýªº¬O¡AÀË¥XÈ0.3¥Nªíªº·N¸q¬°¦ó??Ȫº¤j¤p»Pµo¥Í·»¦åªºÃö«Y¬O§_¦³¥¿¬ÛÃö(¶W¹L12ªºÈ¡A¸ò¤£¨¬3ªºÈ¡A¬O§_¥Nªí·N¸qªº¤£¦P?)ÁÂÁÂ
¶À²W¼wÂå®v¦^ÂСG
±z¦n:Ãö©óÅú¨§¯gªº»Ã¯À½T©w¼ÆÈ¡A¥Ø«e°ê¤ºªº´X®aÂå°|´ú¶qªº¤è¦¡¡A³æ¦ì¡A©M¥¿±`½d³ò¼Æȳ£¤£¬Û¦P¡A©Ò¥HµLªkµ¹±zºë½Tªº¸ê°T¡A¤£¹L0.3³o¼Ëªº¼ÆÈ¡A¦b¦U®aÂå°|À³¸Ó³£ºâ¬O½T©w¬O»Ã¯À¯Ê¥F¡A¤]´N¬O½T©w¬°Åú¨§¯g±wµ£¡A¦Ü©ó·»¦å¤è±¡A¦pªG¤£¬O«ÜÄY«¡AÀ³¸Ó¼vÅT¤£¤j¡AÁÙ¬O«Øij±z¨ì§Aªº½T¶EÂå°|¡A¸ß°Ý±zªºÂå®v½T»{¨äµ²ªG¡C
Åú¨§¯gªºÀË´úÈ3ºâ§C¶Ü?¡H(2004/03/16)
¨à¤l³QÀË´ú¥X¦³Åú¨§¯g¡AÀË´úȬù3¡AÂå¥Í»¡¥¿±`¤H¬O12¥ª¥k¡AÁöµMª¾¹D¬OÁô©Ê¿ò¶Ç¡A¦ý¥Ñ©ó¥À¿Ë¨ÃµL®a±Ú¥v¥X²{¡A·Q½Ð±ÐÂå¥Í---
1.¬O§_·|¦]¬°ÀË´úȦ³®É¨Ã¤£¬O¨º»ò§C¡A©Ò¥H®a¤H¤~¨S¦³²£¥Í·»¦åªº±¡ªp¡H
2.¤S3ªºÀË´úÈ·|¤£·|«ÜÄY«°Ú¡AY¬O¤£¤p¤ß»D¨ì¼Ì¸£¤Y¦h¤[·|¥X²{·»¦åªºª¬ªp¡H
¦¶³ÍÅïÂå®v¦^ÂСG
Åú¨§¯g¬OX¬V¦âÅé©ÊÁp¿ò¶Ç¯e¯f¡A±aìªÌ³q±`¨S¦³¯gª¬¡A¦¹¯Ê¥F¯g²£¥Íªº¯fÅܳ¡¥÷¬O±w«Ä¥»¨°ò¦]ÂIªº¬ðÅÜ¡A¨Ã¤£§¹¥þ¬O¸g¥Ñ¤÷¥À¿ò¶Ç¡A»O¤jÂå°|G6PD¤p©ó5U/gHb¡A¥i¥H½T©w¬O¯f¤H¡AÁקK±µÄ²©`¤Y¡BµµÃĤô©Î¹¥ÎÅú¨§¤Î¬Y¨ÇÃĪ«(¦p¡G¸Ñ¼öÂíµh¾¯¡BÁDÓiÃþ¡B§ÜºÄ¯e¡Bµv°òÃþµ¥)¡A¥i¥H¹w¨¾µo¥Í·»¦å©Ê³h¦å»P¶À¯n²{¶H¡AY¦³³o¨Ç²{¶H»Ý¾¨³t´NÂå¡A¬ÛÃö¤¶²Ð½Ð°Ñ¦Ò¥»ºô¯¸ªº¯e¯f¶µ¥Ø©MÀËÅ礤,¸²µå¿}-¤»-ÁC»ÄÆQ¥h²B»Ã¯À¯Ê¥F¯g(Glucose-6-phosphate dehydrogenase deficiency, G6PD deficiency)¡C
Åú¨§¯gªºÀË´ú¡H(2004/03/12)
¤§«e·s¥Í¨à¦b°ª¥«¸t¥\Âå°|©â¦å§@ÀËÅç¡A«á¨Ó°ªÂå³qª¾§@½ÆÀË¡A§Ú³z¹Lºô¸ô¨t²Î¬d¨ìG6PDȬ°9.4(ºÃ¶§©Ê)¡A«á¨Ó¦b°ªÂå©â¦å½ÆÀË¡AÀˬdȬ°1.3¡A§Ú·Q½Ð°Ý¦b¥x¤j©M°ªÂ媺ÀËÅç¤èªk©M¥¿±`ȬO§_¬Û¦P¡H¬O§_¥i¥Ó½Ð¦A½ÆÀË¡H
¦¶³ÍÅïÂå®v¦^ÂСG
G6PDÀˬdȬ°1.3U/gHb¡AÀ³¬°G6PD¯Ê¥F¯g(Åú¨§¯g)¡A¥x¤jÂå°|G6PD<5U/gHb¥i¥H½T©w¶EÂ_¡A¨CÓÂå°|¦]ÀËÅç¾÷¾¹¤£¦P¡A¼ÆÈ¥i¯à¦³¤@¨Ç®t²§¡A¦ý¬O¦pªG"³æ¦ì"¬Û¦P(U/gHb)¡A¼ÆÈÀ³¸Ó«Ü±µªñ¡C
Åú¨§¨à¥i¥H¦Y¸yªG¡A¨§Ãþªº¹ª«¶Ü?(2004/02/20)
±z¦n:Åú¨§¨à¬O¤£¬O¤£¯à¦YÅú¨§¦Ó¤w¡A¨ä¥Lªº¨§Ãþ¥i¥H¦Y¶Ü???¥ô¦ó«~µPªº¦Ï¥¤¬O§_³£¥i¥H¹¥Î???¶t¯»µ¥¤]¥i¥H¹¥Î¶Ü??§ÚªºÄ_Ä_4Ó¤ë¤F¡A¤£¦P«~µPªº¥¤¯»¥i¥Hªø´Á¤@ª½¹¥Î¶Ü?¦Ó¸zµ±µh¬O§_µ¥©óº¦®ð,¥¤¯»¬O§_¤@©wn¨Ï¥Î»Ä¤Æ¥¤¯»¡A¦¹Ãþªº¥¤¯»¥i¥Hªø´Á¨Ï¥Î¶Ü?? Y¤@¤Ñ¤j¤@~¤G¦¸«K«K¡A¦ý¦³ÂI¸Y¸Yªº¡A¶·nµ¹Âå¥Í¬Ý¶Ü???ÁÂÁÂ~
¶À²»³ÕÂå®v¦^ÂСG
DearµX:Åú¨§¨à¨ä¥Lªº¨§ÃþÀ³¸Ó¬O¥i¥H¦Y¡A¦ýn½T»{¨§Ãþ¤¤½T¹ê¤£²V§tÅú¨§¡A¿ï¾Ü¦Ï¥¤À³¿ï¾Ü¸û¤j¼tµP©Î¦³°ê®a»{ÃÒ¡A¤CÓ¤ë¤jÀ¦¨à°£©T©w³Ü¤û¨Å¡]©Î¥À¨Å¡^¥~¡AÀ³¶}©l²K¥[°Æ¹¡A¦]¤û¨Å¤¤©Ò§t¦³¤j¶qªº¶t½è¡A¥[¤W¦p¤ÑµM¹ª«¶t²K¥[¶q¡AÀ¦¨à©ÒÄá¨úªº¶t½èÁ`¶q§Y¤w¨¬°÷¤F¡A¨Ã¤£»Ýn¦A²K¶t¯»¡AÄ_Ä_4Ó¤ë¡A¦pªG¹ï¦P¼Ë¥¤¯»@¨ü¤£¿ù¡A¤£¶·¤@ª½´«¤£¦P«~µPªº¥¤¯»¡A¸zµ±µh¨Ã¤£µ¥©óº¦®ð¡A¹L¤FÀ¦¨à®É´Á¤j³¡¤À³£·|§ïµ½¡A¤£¤@©wnªø´Á¨Ï¥Î»Ä¤Æ¥¤¯»¡AY¤@¤Ñ¤j¤@~¤G¦¸«K«K¡A¦ý¦³ÂI¸Y¸Yªº¡AÀ³¸ÓÁٺ⥿±`¡A±zY¤£©ñ¤ß¤´«Øij±z§ä·s¥Í¨à¬ìÂå®vµû¦ô¡C
Åú¨§¯gªºÄ_Ä_¥i¥H¥["¤ñµá±o¥Âµß"¶Ü?(2004/01/09)
±z¦n" ¦]¬°§Úªº3Ó¤ë¤jªºÄ_Ä_¡AG¤f¤£¬O«Ü¦n¡A«Ü®e©öº¦®ð¡A¦³®É2¤Ñ¤~¤j¤@¦¸«K¡A«K«o¤S¤ô¤ôªº...©Ò¥H§Ú·Q¥[¤ñµá±o¥Âµß"¦b¤û¥¤¤¤...¦]¥L¬OÅú¨§¨à,¤£ª¾¹D¥i¥H¶Ü??? Y¤j¤H©ê¥L,¦Ó¤j¤Hªº¦çªA¦³¯ä¤Yªº¨ý¹D..·|¦]¦¹¨Ï§¿§¿ªºÃC¦â¥[²`¶Ü???¦³®É¡A§Úµo²{¥Lªº§¿§¿ÃC¦â·|¤ñ¸û²`©O~ÁÂÁ§Aªº¦^µª!!!
¶À²W¼wÂå®v¦^ÂСG
Ãö©ó¤ñµá¼w¤óµß¡AÀ³¸Ó¬O¥i¥H²K¥[ªº¡A¦Ó¦çªA¤Wªº¨ý¹DÁÙ¬OÀ³¸ÓºÉ¶qÁקK¡AÅú¨§¯gªºÄ_Ä_µo¯f¡A°£¤F§¿²GÃC¦âÅܲ`¤§¥~,ÁÙ¦³Áy¦â»a¥Õ¡B¥þ¨¶À¯n¡Bºë¯«¤£¨Îµ¥ª¬ªp¡A¦pªGÁÙ¬O¤£©ñ¤ß¡A«h«Øij±z±aµ¹Âå®v¹î¬Ý¡C
¸É¥R¡G¦æ¬F°|½Ã¥Í¸p¿ò¶Ç¯e¯f¿Ô¸ß¤§¡u½u¤W¿Ô¸ß¡v
http://www.bhp.doh.gov.tw/genetic-counseling/board/index.asp
http://www.weidar.com.tw/FAQ/FAQ0002.htm ½Ð¨£¥H¤Wºô§}¤W±»¡Åú¨§¯g¤£¯à¦Y¶À½¬¡B³½ªo¯uªº¶Ü¡H ÁÂÁÂ2004/06/07
»O¤jÂå°| ¦¶³ÍÅïÂå®v
±z¦n: ®a¶À½¬(coptis teeta),¬O¯óÃĪº¤@ºØ¦¨¤À,¦³§ÜºÄ¯eªº®ÄªG,¦p¦P¨ä¥L§ÜºÄ¯eÃĪ«,¥i¯à·|³y¦¨Åú¨§¯g±wªÌªº·»¦å,³½ªoÄÝ©ó¯×ªÕ,À³¹ïÅú¨§¯g±wªÌ¨S¦³¼vÅT,ÁÂÁÂ
½Ð°Ý¤pÅ@¤h¥i¥H¶î©Ù¶Ü? ¥¦§t¦³9.6%ªºCamphor.§ÚÅ¥»¡Camphor¦³ªº¬O¯Â¤ÑµMªº¼Ì¸£ªo,¹ïÅú¨§¯g¤p«Ä¤£·|¦³¼vÅT,¬O¯uªº¶Ü? 2004/05/22
²z½×¤W¬O¦p¦¹,¦ý¹ê»Ú¤W¬O§_§¹¥þ²Å¦X¼Ð¥Ü,©Î§t¦³¨ä¥LÂø½è«h¤£±o¦Óª¾! ÁÂÁ±zªº¨Ó«H! ¶À²»³ÕÂå®v
½Ð°Ý¡G¤@¡B¼Ì¸£¤Y´N¬O©`¤Y(¯ä¤Y)¶Ü¡H ¤G¡B¦pªGÅú¨§¯gªºÄ_Ä_¸g¹L¼Ì¾ð®Ç»D¨ì¼Ì¾ðªº®ð¨ý·|¤£·|µo¯f©O¡H®a¤H¦pªG¼Q¼Ì¸£ªoÅX°A©Î§O¤HÀ¿¼Ì¸£ªo³QÅú¨§¯gªºÄ_Ä_»D¨ì¤]¤£¦æ¶Ü¡H ¤T¡B§ÚªºÄ_Ä_±w¦³Åú¨§¯g¡AÀˬdµ²ªG«ü¼Æ¬O0.9¡A³o¼Ëªº¼Æ¾Úµ²ªG¡Aµ{«×ºâ¤£ºâ«ÜÄY«©O¡H¥|¡BÄ_Ä_¤W¤½¦@´Z©Ò¡A¦pªG´Z©Ò¸Ì±¦³©ñ¸m©`¤Y(¯ä¤Y)¡A ·|¦³¤°»ò¼vÅT¡H³Â·Ð±z¸Ñ´b¤@¤U¡AÁÂÁ±z¡I¡I¡I2004/01/28
±z¦n: «UºÙªº¼Ì¸£¤Y¡A¨Ã«D¼Ì¾ð¤¤´£·Ò¥X¨Óªº¤ÑµMª«½è¡A¥Ø«e¥xÆW¤j³¡¤Àªº¼Ì¸£¤Y¬O¤Æ¾Ç¦X¦¨,§t¤@ºØ¤Æ¾Ç¦¨¤À¡A¾Ç¦W¥sNaphthalene,¤~¬OP¯fªº¥D¦].©Ò¥H¤@¯ëªº¤ÑµM¼Ì¾ð»s«~À³¸Ó¤£·|¼vÅT.±zªºÄ_Ä_¼ÆȬ°0.9À³¸Ó¬O½T©w¬O§Cªº,¤@¯ë¤p©ó5¥H¤U´Nºâ¯Ê¥F.´Z©Òªº©`¤Y´§µoªº¨ý¹D.À³¸ÓºÉ¶qÁקK»D¨ì.ÁÂÁ±zªº¨Ó«H